Examples of Innovative Financing in Biomedicine
- Ex-Elan execs target €325M IPO for life science fund (FierceBiotech, March 2015)
- Dementia drug research aided by $100 mln venture capital fund (Reuters, March 2015)
- Governments commit to advancements in dementia research and care (WHO Press Release, March 2015)
- Billionaires line up to back Malin's €330M IPO (FierceBiotech, March 2015)
- [London] Mayor considers £10bn 'megafund' as option to boost drug development (Press Release, June 2015)
- UBS cancer fund shows power of impact investing (Barron's, April 2016)
- Clarus raises $910 million for latest drug fund (Boston Globe, July 2017)
- A startup spun out of Pfizer just got $103 million to develop experimental drugs Big Pharma won't (Business Insider, September 2017)
- BridgeBio Pharma raises $135 million from private equity (Business Insider, September 2017)
- Cullinan bags $150M to build a broad slate of cancer assets (FierceBiotech, October 2017)
- KKR, Viking Global lead $299M round for BridgeBio (FierceBiotech, January 2019)
- BridgeBio takes crown for biggest IPO of 2019, as fellow unicorn Adaptive raises offering size and price (Endpoints News, July 2019)
Press
- How better financing could help create new cancer drugs (MIT News, October 2012)
- New ways to pay for progress (Boston Globe Editorial, October 2012)
- School proposes megafund to battle cancer (Financial Times, October 2012)
- MIT economist pitches cancer megafund (The Boston Globe, October 2012)
- A megafund for drug development (Cancer Discovery, November 2012)
- Economist proposes a $30 billion megafund for new cancer drugs (MIT Technology Review, November 2012)
- Disease or cure? How securitisation may help your health (The Economist, January 2013)
- How the world's biggest problem can be fixed with financial engineering (Business Insider, February 2013)
- Financial engineering could heal medical funding ills (Financial Times, June 2013)
- Innovative financing for cancer R&D (Bioentrepreneur—Trade Secrets, June 2013)
- Can Wall Street help cure cancer? (Financial Times, June 2013)
- Beyond venture capital (FasterCures blog, November 2013)
- The megafund model: A solution to curing the largest indications facing mankind? (LSN Newsletter, August 2013)
- Financing a cure for cancer (MIT Sloan Newsroom, January 2014)
- Wall Street's next bet: Cures for rare diseases (Fortune, January 2014)
- Can financial engineering save cancer research? (PBS Newshour Making Sen$e, February 2014)
- To cure cancer, provide a profit motive (Scientific American, March 2014)
- How a new approach to funding Alzheimer's research could pay off (MIT News, June 2014)
- Key to curing Alzheimer's may be changing drug development funding (The Boston Globe, June 2014)
- Shots on goal: Call for a new Alzheimer's drug discovery paradigm (AlzForum, June 2014)
- Should Alzheimer's bonds be issued to fund drug development? (The Wall Street Journal, June 2014)
- Should risker drugs be approved for lethal diseases? (The Washington Post, September 2015)
- How the FDA could change the way it approves drugs (FiveThirtyEight, September 2015)
- MIT prof: To cure cancer, we need pension funds as much as VC firms (Boston Business Journal, September 2015)
- Can Wall Street cure cancer? (ThinkAdvisor, September 2015)
- Rep. Thomas J. Rooney and Rep. Juan Vargas introduce the "Rare Diseases (RaD) Fund Act of 2015" (Press Release, October 2015)
- MIT's Andrew Lo touts megafund to tackle cancer, rare diseases (Institutional Investor, October 2015)
- A case for taking risks on drugs for the dying (The Boston Globe, October 2015)
- Megafunding drug research (Project Syndicate, December 2015)
- This MIT professor thinks Wall Street can fix high health care costs (Wired, February 2016)
- Can't afford the cost of cancer drugs? Get a mortgage (Medscape, March 2016)
- Could financing health care like a home hold down drug costs? (Stat News, March 2016)
- Health care loans offer possible remedy for high US drug costs (Institutional Investor, March 2016)
- Financial engineering helps fight cancer and climate change (Financial Times, June 2016)
- Clinical trial study design: 'one size does not fit all' (Outsourcing-pharma.com, April 2017)
Videos & Podcasts
- Interview with Andrew W. Lo: Could financial engineering cure cancer? (Financial Times, June 2013)
- Andrew W. Lo: Better data for better financial decisions (Congressional Briefing, January 2014)
- Roger M. Stein: A bold new way to fund drug research (TEDxStateStreet, January 2014)
- Will financial engineering cure cancer? (Financial Sense, February 2014)
- Andrew W. Lo: Can financial engineering cure cancer? (TEDxCambridge, October 2015)
- Vikas P. Sukhatme: A simple, one-time, inexpensive and non-toxic intervention to improve cancer survival (MIT Special Seminar, December 2015)
- An Interview with Dr. Laura Esserman: I-SPY Clinical Trials (March 2016)
- HBO Vice - Episode 52: Die Trying (June 2016)
- Andrew W. Lo: Loans for cancer drugs (The Financial Exchange, March 2016)
- Andrew W. Lo: Can Financial Engineering and Data Science Cure Cancer? (Amazon re:MARS, June 2019)